Gerald Brooks

6-(Substituted methylene)penems, potent broad spectrum inhibitors of bacterial .BETA.-lactamase. V. Chiral 1,2,3-triazolyl derivatives.

ISABEL S. BENNETT, Gerald Brooks, N. J. P. BROOM et al. · The Journal of Antibiotics · 1991 · 73 citations · Full text

Novel hydroxyl tricyclics (e.g., GSK966587) as potent inhibitors of bacterial type IIA topoisomerases

Timothy J. Miles, Alan J. Hennessy, B.D. Bax et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 63 citations · Full text

Inhibitory Activity, Medicinal Chemistry, Medicine +13

Protein kinase C down-regulation, and not transient activation, correlates with melanocyte growth.

Gerald Brooks, R. Wilson, Thomas P. Dooley et al. · PubMed · 1991 · 61 citations

Immunology, Cell Proliferation, C Down-regulation +22

Pleuromutilins. Part 1 The identification of novel mutilin 14-carbamates

Gerald Brooks · Bioorganic & Medicinal Chemistry · 2001 · 56 citations

Novel Mutilin 14-Carbamates, Pathology, Pleural Disease +2

Novel cyclohexyl-amides as potent antibacterials targeting bacterial type IIA topoisomerases

Timothy J. Miles, Christopher W. Barfoot, Gerald Brooks et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 49 citations · Full text

Medicine, Novel Cyclohexyl-amides, Antibacterial Agent +7